Dr Fernand Noel Parent Jr, MD | |
426 W Main St, Monongahela, PA 15063-2552 | |
(724) 258-7700 | |
(724) 258-3220 |
Full Name | Dr Fernand Noel Parent Jr |
---|---|
Gender | Male |
Speciality | General Practice |
Experience | 67 Years |
Location | 426 W Main St, Monongahela, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700974649 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | MD026319L (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Amedisys Home Health Of Pa | Uniontown, PA | Home health agency |
Monongahela Valley Hospital | Monongahela, PA | Hospital |
Mailing Address | Practice Location Address |
---|---|
Dr Fernand Noel Parent Jr, MD 426 W Main St, Monongahela, PA 15063-2552 Ph: (724) 258-7700 | Dr Fernand Noel Parent Jr, MD 426 W Main St, Monongahela, PA 15063-2552 Ph: (724) 258-7700 |
News Archive
Kimberly-Clark Corporation today reported first quarter 2015 results and confirmed its previous guidance for full-year 2015 adjusted earnings per share.
Research led by Ashok Aiyar, PhD, Associate Professor of Microbiology at LSU Health Sciences Center New Orleans, showing that a single gene can control growth in cancers related to the Epstein-Barr virus and that existing therapeutics can inactivate it, will be published in the June 12, 2009 online issue of PLoS Pathogens.
The incidence of rheumatoid arthritis (RA) in women has risen during the period of 1995 to 2007, according to a newly published study by researchers from the Mayo Clinic. This rise in RA follows a 4-decade period of decline and study authors speculate environmental factors such as cigarette smoking, vitamin D deficiency, and lower dose synthetic estrogens in oral contraceptives may be the source of the increase.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced it is expanding its global cell culture and bioprocessing capabilities by opening a new manufacturing plant in Singapore to produce dry powder media, a crucial cell culture raw material used to manufacture biologics, including vaccines, anti-cancer therapeutics, and others.
› Verified 6 days ago